Biogen will stop selling its controversial Alzheimer’s drug Aduhelm
Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago. The drugmaker also said Wednesday …